Clinical Trial Update: Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the combination of anidulafungin and voriconazole to voriconazole alone for invasive aspergillosis has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Anidulafungin (anidulafungin)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Aspergillosis | Phase 3 | Status: COMPLETED | Results posted: 2012-04-30